Among crucial development in 2019 are:
- FoundationOne Foundation One test — a single test that analyzes all guideline-recommended genes for solid tumors, including correctional, breast, ovarian, and melanoma. It helps to select the most adequate hypnotherapy for treatment.
- A new experimental medicine for reticulation, cancer affecting children’s eyes. The medicine is based on VCN-01 oncologist virus, a genetically modified pathogen which attacks and destroys the cancer cells. It is hope for 30% of those who do not respond to conventional therapies.
- The new drug tisotumab vedotin (TV for short) sneaks into cancer cells and kill them from within. The cancer patients with advanced types or resistant to standard treatments responded to the innovative new drug with their tumors either shrinking or stopping growing. The positive results have moved the drug forward to phase II trials.
No comments:
Post a Comment